Balance Sheet

v3.24.1

Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 1,173	$ 4,391
Short-term marketable securities		2,049
Prepaid expenses and other current assets	192	825
Deferred offering costs	101
Total assets	1,466	7,265
Current liabilities:
Accounts payable	561	534
Accrued expenses	614	568
Total current liabilities	1,175	1,102
Common stock warrant liability	3,291
Total liabilities	4,466	1,102
Commitments and contingencies (Note 6)
Convertible preferred stock and stockholders’ equity (deficit):
Convertible preferred stock, $0.0001 par value; 15,000,000 shares authorized as of December 31, 2023 and 2022, respectively; zero shares issued and outstanding at December 31, 2023 and 2022, respectively
Common stock, $0.0001 par value, 250,000,000 shares authorized at December 31, 2023, and 2022, respectively; 10,693,580 and 9,097,701 shares issued and outstanding as of December 31, 2023, and 2022, respectively	1	1
Additional paid-in capital	38,404	37,318
Accumulated other comprehensive income		17
Accumulated deficit	(41,405)	(31,173)
Total convertible preferred stock and stockholders’ (deficit) equity	(3,000)	6,163
Total liabilities, convertible preferred stock and stockholders’ equity (deficit)	$ 1,466	$ 7,265

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Source

Delivering Therapy Where it Matters

Quicklinks

Delivering Therapy Where it Matters

Quicklinks